Previous Close | 320.31 |
1-Year Change | 5.19% |
6-Months Change | 9% |
3-Months Change | -1.84% |
Moving Avg (50d) | 340.44 |
Moving Avg (200d) | 317.29 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 9.32B |
Beta (3-Years) | 0.95 |
Revenue Growth (ttm) | -3.01% |
Net Profit Margin (ttm) | -5.86% |
Return On Assets (ttm) | -1.34% |
EPS (ttm) | -5.85 |
PE Ratio (ttm) | -54.75 |
Dividend Yield | % |
Asset Description: | Bio-Rad Laboratories, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-10-30 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
317.216 | 307.506 | 301.032 | 291.321 | 275.137 | 258.952 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide.... Wikipedia